Dyskeratosis congenita has been found to be associated with abnormal immune function. In this study we report a patient with this association. He developed Pneumocystis carinii interstitial pneumonia, and impaired cell mediated immunity was confirmed by the presence of depressed lymphoproliferative responses to in vitro stimulation with mitogen. Enumeration of T cell subsets showed a severely depressed CD4:CD8 ratio (0.38), which is the likely cause for impaired cell mediated immunity. The T cell activation pathway appeared intact, as his T lymphocytes were able to express activation markers (CD25 and HLA-DR) after mitogen stimulation.
Dyskeratosis congenita is a rare, heritable, multisystem disorder, characterised by reticulate skin hyperpigmentation, mucosal leucoplakia, and nail dystrophy. More serious features are bone marrow involvement with pancytopenia and a predisposition to malignancy. Although the primary defect has not been identified, an X linked mode of inheritance has been shown in the majority of cases. ' Recently, linkage in one large family by using X chromosome specific RFLP markers has assigned the gene for dyskeratosis congenita to chromosome band Xq28.' Several families with apparent autosomal forms of dyskeratosis congenita have also been reported, suggesting aetiological heterogeneity in this disorder.3 4
Chromosome breakage is not a consistent finding, although enhanced G2 chromatid radiosensitivity has been observed in the fibroblasts. 5 This phenomenon has been observed in individuals genetically predisposed to cancer,6 a characteristic also observed in dyskeratosis congenita. Patients with this disorder are also prone to opportunistic infections, and immunological abnormalities which include both humoral and cell mediated dysfunction. We report a case of dyskeratosis congenita with abnormalities in T cell subsets and impaired lymphoproliferative responses to in vitro stimulation with mitogens.
Case study A 15 year old boy presented with characteristic dermatological features ofdyskeratosis congenita which he had had since the age of 3 years. These included reticulate skin pigmentation, dystrophic nails, and oral mucosa leucoplakia. He had been immunised, including BCG, without complications. At the age of 10 years he had developed thrombocytopenia, which had progressed over the next few years to pancytopenia associated with bone marrow hypoplasia. At this stage a bone marrow transplantation was considered, but his parents refused consent. At the age of 15 he developed Pneumocystis carinii interstitial pneumonia, which was confirmed by the presence of protozoan cysts in the bronchial alveolar lavage. He responded to treatment with intravenous high dose co-trimoxazole. His male cousin (maternal side) was also similarly affected with dyskeratosis congenita, and died from sepsis at the age of 10 years.
His total white counts fluctuated from 6-4 to 0 8x l09/l, with absolute lymphocyte counts of 2 5 to <0 8x 109/1. 
Discussion
Dyskeratosis congenita is a genetic condition which is ultimately lethal. We have previously reported the characteristic mucocutaneous features in two of our local patients with this disease.7 Abnormalities in immune function in this disorder is evidenced by a high incidence of unusual infections, and the primary causes of death are infections and carcinoma. In this study, our patient with dyskeratosis congenita and depressed cell mediated immunity developed interstitial pneumonia due to P carinii infection; this is an opportunistic infection usually affecting patients with depressed T cell function.
There have been other reports of abnormalities of cell mediated immunity in dyskeratosis congenita. These have included absence or delayed hypersensitivity to a battery of skin test antigens,3 and impaired response to mitogenic stimulation upon in vitro testing.8 Our patient also showed impaired lymphoproliferative responses to in vitro stimulation with mitogens (table 2). The mechanism for the impaired cell mediated function has not been delineated. As shown in this study, the presence of a markedly depressed CD4:CD8 ratio (038) and decrease in absolute CD4 positive cells are likely contributing factors. The T cell activation pathway appears to be intact since the patient's T cells were able to express normally the activation marker CD25 and HLA-DR ( IgM,'2 and increased IgG.13 Our patient had hypergammaglobulinaemia. With the presence of cell mediated abnormality, as seen in our patient, it is tempting to postulate that the dysgammaglobulinaemia may result from abnormal T cell help, similar to that seen in paediatric acquired immune deficiency syndrome. 14 Interestingly, the genes for dyskeratosis congenita and X linked severe combined immunodeficiency, a condition also associated with depressed cellular and humoral immunity, have both been located on the long arm of the X chromosome. Their locations on the long arm of the X chromosome differ, with the former located in the Xq282 band and the latter between region Xql3.1 and Xq21. L '5 congenita. 
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